Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sommadossi

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
Arzneimittel-Forschung|January 1, 1981
Comparative determinations of 5-fluorouracil in plasma using GC/MS and HPLCC Aubert, C Luccioni, P Coassolo, et al.
Biochemical Pharmacology|November 17, 1992
Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cellsJ P Sommadossi, R F Schinazi, C K Chu, et al.
Cancer Research|October 1, 1985
Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cellsR B Diasio, J D Schuetz, H J Wallace, et al.
Molecular Pharmacology|February 1, 1992
Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cellsD A Weidner, E G Bridges, E M Cretton, et al.
Biochemical Pharmacology|January 15, 1991
3'-Azido-3'-deoxythymidine inhibition of human lymphocyte cytolytic function in vitroD R Shaw, D R Knight, A L Waterman, et al.
Therapie|May 1, 1980
[The advantages and limitations of posology rationalization (author's transl)]J P Sommadossi, C Aubert, J P Cano, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patientsC Coustère, F Mentré, J P Sommadossi, et al.
Plos One|January 9, 2020
Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virusSteven S Good, Adel Moussa, Xiao-Jian Zhou, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Pharmacologic studies of nucleosides active against the human immunodeficiency virusJ P Sommadossi, Z Zhu, R Carlisle, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeysE Cretton-Scott, L Placidi, H McClure, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
Arzneimittel-Forschung|January 1, 1981
Comparative determinations of 5-fluorouracil in plasma using GC/MS and HPLCC Aubert, C Luccioni, P Coassolo, et al.
Biochemical Pharmacology|November 17, 1992
Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cellsJ P Sommadossi, R F Schinazi, C K Chu, et al.
Cancer Research|October 1, 1985
Dihydrofluorouracil, a fluorouracil catabolite with antitumor activity in murine and human cellsR B Diasio, J D Schuetz, H J Wallace, et al.
Molecular Pharmacology|February 1, 1992
Comparative effects of 3'-azido-3'-deoxythymidine and its metabolite 3'-amino-3'-deoxythymidine on hemoglobin synthesis in K-562 human leukemia cellsD A Weidner, E G Bridges, E M Cretton, et al.
Biochemical Pharmacology|January 15, 1991
3'-Azido-3'-deoxythymidine inhibition of human lymphocyte cytolytic function in vitroD R Shaw, D R Knight, A L Waterman, et al.
Therapie|May 1, 1980
[The advantages and limitations of posology rationalization (author's transl)]J P Sommadossi, C Aubert, J P Cano, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
A mathematical model of the kinetics of 5-fluorouracil and its metabolites in cancer patientsC Coustère, F Mentré, J P Sommadossi, et al.
Plos One|January 9, 2020
Preclinical evaluation of AT-527, a novel guanosine nucleotide prodrug with potent, pan-genotypic activity against hepatitis C virusSteven S Good, Adel Moussa, Xiao-Jian Zhou, et al.
Annals of the New York Academy of Sciences|January 1, 1990
Pharmacologic studies of nucleosides active against the human immunodeficiency virusJ P Sommadossi, Z Zhu, R Carlisle, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1996
Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeysE Cretton-Scott, L Placidi, H McClure, et al.
Pageof 18